Furthermore, comparison of the three PMD groups revealed that the Alpers’ syndrome patients demonstrated significantly lower expression of COXI in comparison to the mtDNA disease group (P = 0.0406). This evidence concerns the gene MT-CO1 and Pelizeaus-Merzbacher spectrum disorder.